POMPANO BEACH, Fla., Oct. 18, 2017 /PRNewswire/ -- GVCL Ventures, Inc. (the "Company") (OTC: GVCL), today announces the terminationof the Company's joint venture agreement (the "Joint Venture Agreement") with Pyramidion Technology Group, Inc. ("PYTG") and continues to pursue new business opportunities in a number of value enhanced industries.
The Company was not advised
The Company also announces that it was flagged by the OTC Markets Group ("OTC Markets") for promotional activities and labelled with Caveat Emptor. On September 11, 2017, the Company was advised by OTC Markets of unauthorized, third party promotional activities. Neither the Company nor any of its affiliates solicited or paid for any investor relations or other third party reports. The Company has been in communication with OTC Markets regarding this matter. The Company confirms it is fully compliant with its current reporting requirements. The Company further confirms it is not nor has been involved in any type of stock promotion activities.
About GVCL Ventures, Inc.:
GVCL Ventures, Inc. (www.gvclventures.com), is a business opportunity company with a focus on operational Cannabis, Hemp and CBD companies to work with for the purpose of enhancing shareholder value, in symphony with its wholly owned subsidiary, GVCL Marketing Corp., which provides a unique network marketing opportunity that utilizes its extensive access to online digital campaigns via the internet for its clients and partners, to enhance their productivity and revenue.
Forward Looking StatementsUndue reliance should not be placed on forward looking statements in this press release. This press release contains forward looking statements that involve risks and uncertainties. Words such as "will," "anticipates," "believes," "plans," "goal," "expects," "future," "intends," and similar expressions are used to identify these forward looking statements. Actual results could materially differ from those anticipated in these forward looking statements for many reasons.
View original content:http://www.prnewswire.com/news-releases/gvcl-ventures-inc-issues-shareholder-update-300539382.html
SOURCE GVCL Ventures, Inc.
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All